Chung LW - Search Results

1

Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines.

Wu TT, Sikes RA, Cui Q, Thalmann GN, Kao C, Murphy CF, Yang H, Zhau HE, Balian G, Chung LW. Wu TT, et al. Among authors: chung lw. Int J Cancer. 1998 Sep 11;77(6):887-94. doi: 10.1002/(sici)1097-0215(19980911)77:6<887::aid-ijc15>3.0.co;2-z. Int J Cancer. 1998. PMID: 9714059

2

Honokiol, a natural plant product, inhibits the bone metastatic growth of human prostate cancer cells.

Shigemura K, Arbiser JL, Sun SY, Zayzafoon M, Johnstone PA, Fujisawa M, Gotoh A, Weksler B, Zhau HE, Chung LW. Shigemura K, et al. Among authors: chung lw. Cancer. 2007 Apr 1;109(7):1279-89. doi: 10.1002/cncr.22551. Cancer. 2007. PMID: 17326044 Free article.

3

Cellular interactions in the tropism of prostate cancer to bone.

Sikes RA, Nicholson BE, Koeneman KS, Edlund NM, Bissonette EA, Bradley MJ, Thalmann GN, Cecchini MG, Pienta KJ, Chung LW. Sikes RA, et al. Among authors: chung lw. Int J Cancer. 2004 Jul 1;110(4):497-503. doi: 10.1002/ijc.20153. Int J Cancer. 2004. PMID: 15122581

4

Acquisition of a tumorigenic phenotype by a rat ventral prostate epithelial cell line expressing a transfected activated neu oncogene.

Sikes RA, Chung LW. Sikes RA, et al. Among authors: chung lw. Cancer Res. 1992 Jun 1;52(11):3174-81. Cancer Res. 1992. PMID: 1350510

5

Co-inoculation of tumorigenic rat prostate mesenchymal cells with non-tumorigenic epithelial cells results in the development of carcinosarcoma in syngeneic and athymic animals.

Chung LW, Chang SM, Bell C, Zhau HE, Ro JY, von Eschenbach AC. Chung LW, et al. Int J Cancer. 1989 Jun 15;43(6):1179-87. doi: 10.1002/ijc.2910430636. Int J Cancer. 1989. PMID: 2732007

6

A fetal rat urogenital sinus mesenchymal cell line (rUGM): accelerated growth and conferral of androgen-induced growth responsiveness upon a human bladder cancer epithelial cell line in vivo.

Zhau HE, Hong SJ, Chung LW. Zhau HE, et al. Among authors: chung lw. Int J Cancer. 1994 Mar 1;56(5):706-14. doi: 10.1002/ijc.2910560516. Int J Cancer. 1994. PMID: 7508897

7

Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer.

Thalmann GN, Anezinis PE, Chang SM, Zhau HE, Kim EE, Hopwood VL, Pathak S, von Eschenbach AC, Chung LW. Thalmann GN, et al. Among authors: chung lw. Cancer Res. 1994 May 15;54(10):2577-81. Cancer Res. 1994. PMID: 8168083

8

Suramin-induced decrease in prostate-specific antigen expression with no effect on tumor growth in the LNCaP model of human prostate cancer.

Thalmann GN, Sikes RA, Chang SM, Johnston DA, von Eschenbach AC, Chung LW. Thalmann GN, et al. Among authors: chung lw. J Natl Cancer Inst. 1996 Jun 19;88(12):794-801. doi: 10.1093/jnci/88.12.794. J Natl Cancer Inst. 1996. PMID: 8637045

9

Osteocalcin promoter-based toxic gene therapy for the treatment of osteosarcoma in experimental models.

Ko SC, Cheon J, Kao C, Gotoh A, Shirakawa T, Sikes RA, Karsenty G, Chung LW. Ko SC, et al. Among authors: chung lw. Cancer Res. 1996 Oct 15;56(20):4614-9. Cancer Res. 1996. PMID: 8840973

10

Molecular therapy with recombinant p53 adenovirus in an androgen-independent, metastatic human prostate cancer model.

Ko SC, Gotoh A, Thalmann GN, Zhau HE, Johnston DA, Zhang WW, Kao C, Chung LW. Ko SC, et al. Among authors: chung lw. Hum Gene Ther. 1996 Sep 10;7(14):1683-91. doi: 10.1089/hum.1996.7.14-1683. Hum Gene Ther. 1996. PMID: 8886839

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

431 results

Search Page

Filters